Michael Heneka to Enzyme Activation
This is a "connection" page, showing publications Michael Heneka has written about Enzyme Activation.
Connection Strength
0.105
-
H?ll M, Berger M, Heneka M. Disease-modifying therapies in Alzheimer's disease: how far have we come? Drugs. 2006; 66(16):2075-93.
Score: 0.060
-
van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, B?umer V, Engelborghs S, De Bleecker J, Baets J, Gelpi E, Rojas-Garc?a R, Clarim?n J, Lle? A, Diehl-Schmid J, Alexopoulos P, Perneczky R, Synofzik M, Just J, Sch?ls L, Graff C, Thonberg H, Borroni B, Padovani A, Jordanova A, Sarafov S, Tournev I, de Mendon?a A, Miltenberger-Milt?nyi G, Sim?es do Couto F, Ramirez A, Jessen F, Heneka MT, G?mez-Tortosa E, Danek A, Cras P, Vandenberghe R, De Jonghe P, De Deyn PP, Sleegers K, Cruts M, Van Broeckhoven C, Goeman J, Nuytten D, Smets K, Robberecht W, Damme PV, Bleecker J, Santens P, Dermaut B, Versijpt J, Michotte A, Ivanoiu A, Deryck O, Bergmans B, Delbeck J, Bruyland M, Willems C, Salmon E, Pastor P, Ortega-Cubero S, Benussi L, Ghidoni R, Binetti G, Hern?ndez I, Boada M, Ruiz A, Sorbi S, Nacmias B, Bagnoli S, Sorbi S, Sanchez-Valle R, Llado A, Santana I, Ros?rio Almeida M, Frisoni GB, Maetzler W, Matej R, Fraidakis MJ, Kovacs GG, Fabrizi GM, Testi S. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017 03; 38(3):297-309.
Score: 0.032
-
Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem. 2004 Jan; 88(2):494-501.
Score: 0.013